A Phase II Study to Evaluate Efficacy and Safety of P276-00 in Relapsed and/or Refractory Mantle Cell Lymphoma

Summary

The purpose of this study is to determine whether P276-00 is safe and effective in treatment of Mantle Cell Lymphoma that is recurred after or not responding to at least one previous line of treatment.

Timeline

Start

2009-11

Primary completion

2011-02

Completion

2012-08

Outcome

Outcome not reported

Stopped: “The study was terminated based on interim results and all subjects were off study at that time. No major safety or tolerability concerns”

Drugs

Indications